Huntington Study Group Announces Call for Abstracts for 30th Annual Meeting
Summary
Rochester, NY, June 01, 2023 --( PR.com )-- The Huntington Study Group (HSG), with a mission of accelerating treatments that make a difference for those affected by Huntington’s disease, together with its wholly owned subsidiary, HSG Clinical Research, Inc., a world leader in conducting clinical trials for Huntington’s disease (HD), today announces that the submission period has begun for abstracts to be considered for presentation at their 30th Annual Meeting in November (“HSG 2023”).For decades at their Annual Meeting, HSG has provided an opportunity for researchers to present valuable findings and information about HD clinical research to event attendees through poster sessions and platform presentations during the Peter Como HD Research Symposium. I always look forward to reviewing the exceptional science and innovation focused on advancing our understanding and treatment options for HD.”The deadline for abstract submission is July 31, 2023. Authors will be asked to disclose relationships with funding sources and manufacturers of commercial products discussed in the presentations. To learn more or submit your research for consideration, visit https://www.judgify.me/HSG2023 If you would like to sponsor this year’s poster sessions, please contact us at info@hsglimited.org . HSG is dedicated to improving the lives of people impacted by Huntington’s disease through research, education, and collaboration.
Classifications
AskAI Classifications
LabelsLinked Companies
